Abstract

Actinobacillus pleuropneumoniae (APP) is one major bacterial porcine respiratory tract pathogen causing disease outbreaks worldwide, although effective commercial vaccines are available. Due to frequent failure of this preventive measure, treatment with antimicrobials is indispensable to prevent animal losses within an outbreak situation. To preserve the effectivity of antimicrobial substances to fight APP should therefore be the primary aim of any interventions. In this study, the temporal development of antimicrobial resistance in APP was analyzed retrospectively in the time period 2006–2020 from a routine diagnostic database. In parallel, frequent coinfections were evaluated to identify most important biotic cofactors as important triggers for disease outbreaks in endemically infected herds. The proportion of APP serotype 2 decreased over time but was isolated most often from diseased swine (57% in 2020). In ~1% of the cases, APP was isolated from body sites outside the respiratory tract as brain and joints. The lowest frequencies of resistant isolates were found for cephalothin and ceftiofur (0.18%), florfenicol (0.24%), tilmicosin (2.4%), tiamulin (2.4%), enrofloxacin (2.7%), and spectinomycin (3.6%), while the highest frequencies of resistant isolates were found for gentamicin (30.9%), penicillin (51.5%), and tetracycline (78.2%). For enrofloxacin, tiamulin, tilmicosin, and tetracycline, significantly lower frequencies of resistant isolates were found in the time period 2015–2020 compared to 2006–2014, while gentamicin-resistant isolates increased. In summary, there is only a low risk of treatment failure due to resistant isolates. In maximum, up to six coinfecting pathogens were identified in pigs positive for APP. Most often pigs were coinfected with Porcine Circovirus 2 (56%), Streptococcus suis (24.8%), or the Porcine Reproductive and Respiratory Syndrome Virus (23.3%). Potential synergistic effects between these pathogens published from experimental findings can be hypothesized by these field data as well. To prevent APP disease outbreaks in endemically infected herds more efficiently in the future, next to environmental trigger factors, preventive measures must also address the coinfecting agents.

Highlights

  • Actinobacillus (A.) pleuropneumoniae (APP) is causing peracute, acute, and chronic infections in swine worldwide

  • Routine diagnostic data from swine with respiratory diseases in a swine-dense region in North Western Germany were evaluated with respect to the primary respiratory tract pathogen APP

  • 1% of the isolates originated from body sites outside the respiratory tract, as brain and joints

Read more

Summary

Introduction

Actinobacillus (A.) pleuropneumoniae (APP) is causing peracute, acute, and chronic infections in swine worldwide. Occurring subclinical diseases in these farms are reflected by recent results of slaughterhouse lung evaluation for dorso-caudal pleurisy suspicious of APP. Due to the high proportion of positive farms, sudden outbreaks of acute disease are in the majority of cases linked to the presence of the pathogen but triggered by additional factors as environmental stressors or coinfecting agents. Severe disease outbreaks with high mortality after introduction of the pathogen by carrier animals in a naïve herd are rare but economically devastating events. In both cases, measures to deal with disease are (a) immediate antibiotic treatment to prevent further losses, (b) vaccination, (c) treatment and prevention of coinfecting agents, and (d) identification and elimination of environmental stressors. The most important coinfecting agents as disease triggers should be known to interpret ambiguous diagnostic findings commonly observed under field conditions

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.